The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable
出版年份 2019 全文链接
标题
The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 295, Issue 2, Pages 403-414
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2019-12-03
DOI
10.1074/jbc.ra119.011268
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
- (2018) Liriye Kurtovic et al. BMC Medicine
- The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites
- (2018) Marije C. Behet et al. INFECTION AND IMMUNITY
- Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum
- (2018) Susheel K. Singh et al. Microbial Cell Factories
- A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
- (2018) Joshua Tan et al. NATURE MEDICINE
- A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
- (2018) Neville K Kisalu et al. NATURE MEDICINE
- The GMZ2 malaria vaccine: from concept to efficacy in humans
- (2017) Michael Theisen et al. Expert Review of Vaccines
- Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria
- (2017) Ikhlaq Hussain Kana et al. JOURNAL OF INFECTIOUS DISEASES
- Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
- (2017) Susheel K. Singh et al. Microbial Cell Factories
- Structural basis for antibody recognition of the NANP repeats inPlasmodium falciparumcircumsporozoite protein
- (2017) David Oyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection
- (2017) Diego A. Espinosa et al. npj Vaccines
- Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
- (2017) Katharine A. Collins et al. Scientific Reports
- Analysis of the dose-dependent stage-specific in vitro efficacy of a multi-stage malaria vaccine candidate cocktail
- (2016) Alexander Boes et al. MALARIA JOURNAL
- Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
- (2016) Bright Adu et al. MALARIA JOURNAL
- A Comprehensive Analysis of Plasmodium Circumsporozoite Protein Binding to Hepatocytes
- (2016) Jinghua Zhao et al. PLoS One
- The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
- (2016) Roly Gosling et al. PLOS MEDICINE
- Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains
- (2015) Raul Herrera et al. INFECTION AND IMMUNITY
- A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies
- (2015) Susheel K. Singh et al. VACCINE
- A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate
- (2014) Amy R. Noe et al. PLoS One
- IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
- (2014) Robert Schwenk et al. PLoS One
- A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages
- (2014) Michael Theisen et al. VACCINE
- Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection
- (2013) Lander Foquet et al. JOURNAL OF CLINICAL INVESTIGATION
- Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+T Cell Immunity and Protection in Mice
- (2012) Kathrin Kastenmüller et al. INFECTION AND IMMUNITY
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Unexpected fold in the circumsporozoite protein target of malaria vaccines
- (2012) M. B. Doud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate
- (2011) Susana Lousada-Dietrich et al. VACCINE
- A Research Agenda to Underpin Malaria Eradication
- (2011) Pedro L. Alonso et al. PLOS MEDICINE
- Structure of thePlasmodium falciparumCircumsporozoite Protein, a Leading Malaria Vaccine Candidate
- (2009) Matthew L. Plassmeyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protective CD8+T cells againstPlasmodiumliver stages: immunobiology of an ‘unnatural’ immune response
- (2008) Michael Glen Overstreet et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More